◆英語タイトル:VistaGen Therapeutics Inc (VTGN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7041
◆発行会社(調査会社):
GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company’s pipeline product, AV-101, currently under Phase 2 clinical development, is an oral N-methyl-D-aspartate receptor glycine B intended to treat major depressive disorder. It conducts research on their human pluripotent stem cell platform to predict toxic chemicals in heart. The company conducts clinical trials of its product in treatment of chronic neuropathic pain, epilepsy, huntington’s disease and parkinson’s disease. It partners with other healthcare industries for researching and assessing the drug effects on cardiac risk. VistaGen is headquartered in South San Francisco, California, the US.
VistaGen Therapeutics Inc (VTGN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
VistaGen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
VistaGen Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
VistaGen Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
VistaGen Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
VistaGen Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
VistaGen Therapeutics Inc, Medical Equipment, Deal Details 10
Partnerships 10
VistaGen Therapeutics Enters Into Agreement With Celsis In Vitro Technologies 10
Equity Offering 11
VistaGen Therapeutics Raises USD4.8 Million in Private Placement of Shares 11
VistaGen Therapeutics Raises USD15 Million in Public Offering of Shares and Warrants 12
Vistagen Therapeutics Raises USD2.4 Million in Public Offering of Shares and Warrants 13
VistaGen Therapeutics Raises USD10 Million in Public Offering of Shares and Warrants 15
VistaGen Therapeutics Completes First Tranche Of Private Placement Of Shares For US$0.025 Million 17
VistaGen Therapeutics Inc – Key Competitors 18
VistaGen Therapeutics Inc – Key Employees 19
VistaGen Therapeutics Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 14, 2018: VistaGen Therapeutics announces fiscal 2019 first quarter financial results 21
Jun 26, 2018: VistaGen Therapeutics Announces Fiscal Year 2018 Financial Results 23
Feb 12, 2018: VistaGen Therapeutics Reports Third Quarter Fiscal 2018 Financial Results 25
Nov 09, 2017: VistaGen Therapeutics Reports Second Fiscal Quarter 2018 Financial Results and Provides Business Update 26
Aug 14, 2017: VistaGen Therapeutics Reports First Fiscal Quarter 2018 Financial Results and Provides Business Update 27
Jun 29, 2017: VistaGen Therapeutics Reports Fiscal 2017 Financial Results and Provides Corporate Update 29
Feb 13, 2017: VistaGen Therapeutics Reports Fiscal Third Quarter 2017 Financial Results and Provides Corporate Update 31
Corporate Communications 33
Aug 21, 2017: VistaGen Therapeutics Expands VistaStem’s Scientific Advisory Board with Appointment of Medicinal Chemistry Expert, David Rotella, PhD 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34
List of Tables
VistaGen Therapeutics Inc, Medical Equipment, Key Facts, 2018 2
VistaGen Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
VistaGen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
VistaGen Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
VistaGen Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
VistaGen Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
VistaGen Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
VistaGen Therapeutics Enters Into Agreement With Celsis In Vitro Technologies 10
VistaGen Therapeutics Raises USD4.8 Million in Private Placement of Shares 11
VistaGen Therapeutics Raises USD15 Million in Public Offering of Shares and Warrants 12
Vistagen Therapeutics Raises USD2.4 Million in Public Offering of Shares and Warrants 13
VistaGen Therapeutics Raises USD10 Million in Public Offering of Shares and Warrants 15
VistaGen Therapeutics Completes First Tranche Of Private Placement Of Shares For US$0.025 Million 17
VistaGen Therapeutics Inc, Key Competitors 18
VistaGen Therapeutics Inc, Key Employees 19
VistaGen Therapeutics Inc, Subsidiaries 20
List of Figures
VistaGen Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
VistaGen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
VistaGen Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
VistaGen Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
VistaGen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
VistaGen Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
VistaGen Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
VistaGen Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8